<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>400</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>12874380</PubmedId>
            <Abstract>Multiple sclerosis is a chronic disease of the central nervous system (CNS) characterized by inflammation, demyelination, and axonal loss. The immunopathogenesis of demyelination in multiple sclerosis involves an autoantibody response to myelin oligodendrocyte glycoprotein (MOG), a type I transmembrane protein located at the surface of CNS myelin. Here we present the crystal structures of the extracellular domain of MOG (MOGIgd) at 1.45-A resolution and the complex of MOGIgd with the antigen-binding fragment (Fab) of the MOG-specific demyelinating monoclonal antibody 8-18C5 at 3.0-A resolution. MOGIgd adopts an IgV like fold with the A'GFCC'C" sheet harboring a cavity similar to the one used by the costimulatory molecule B7-2 to bind its ligand CTLA4. The antibody 8-18C5 binds to three loops located at the membrane-distal side of MOG with a surprisingly dominant contribution made by MOG residues 101-108 containing a strained loop that forms the upper edge of the putative ligand binding site. The sequence R101DHSYQEE108 is unique for MOG, whereas large parts of the remaining sequence are conserved in potentially tolerogenic MOG homologues expressed outside the immuno-privileged environment of the CNS. Strikingly, the only sequence identical to DHSYQEE was found in a Chlamydia trachomatis protein of unknown function, raising the possibility that Chlamydia infections may play a role in the MOG-specific autoimmune response in man. Our data provide the structural basis for the development of diagnostic and therapeutic strategies targeting the pathogenic autoantibody response to MOG.</Abstract>
            <ArticleYear>2003</ArticleYear>
            <ArticlePages>9446-51</ArticlePages>
            <ArticleTitle>Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Breithaupt</LastName>
                    <ForeName>Constanze</ForeName>
                </Author>
                <Author>
                    <LastName>Schubart</LastName>
                    <ForeName>Anna</ForeName>
                </Author>
                <Author>
                    <LastName>Zander</LastName>
                    <ForeName>Hilke</ForeName>
                </Author>
                <Author>
                    <LastName>Skerra</LastName>
                    <ForeName>Arne</ForeName>
                </Author>
                <Author>
                    <LastName>Huber</LastName>
                    <ForeName>Robert</ForeName>
                </Author>
                <Author>
                    <LastName>Linington</LastName>
                    <ForeName>Christopher</ForeName>
                </Author>
                <Author>
                    <LastName>Jacob</LastName>
                    <ForeName>Uwe</ForeName>
                </Author>
            </Authors>
            <Affiliations>Abteilung Strukturforschung, Max-Planck-Institut für Biochemie, Am Klopferspitz 18a, 82152 Martinsried, Germany. breitha@biochem.mpg.de.</Affiliations>
            <ArticleChemicalList>Antigens;Ligands;Mog protein, rat;Myelin Proteins;Myelin-Associated Glycoprotein;Myelin-Oligodendrocyte Glycoprotein</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Animals; Antigens(chemistry); Binding Sites; Cell Membrane(metabolism); Chlamydia trachomatis(metabolism); Crystallography, X-Ray; Escherichia coli(metabolism); Ligands; Models, Molecular; Molecular Sequence Data; Myelin Proteins; Myelin-Associated Glycoprotein(chemistry; immunology); Myelin-Oligodendrocyte Glycoprotein; Protein Conformation; Protein Folding; Protein Structure, Tertiary; Rats; Sequence Homology, Amino Acid</ArticleMeshHeadingsList>
            <Journal>
                <Volume>100</Volume>
                <Issue>16</Issue>
                <Title>Proceedings of the National Academy of Sciences of the United States of America</Title>
                <Issn>0027-8424</Issn>
                <MedlineTa>Proc Natl Acad Sci U S A</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>mAb 8-18C5 - MOG epitope</EpitopeName>
                <EpitopeStructure>
                    <DiscontinuousRegionOnAccessionSequenceMolecule>
                        <ChemicalType>Discontinuous protein residues</ChemicalType>
                        <DiscontinuousResidues>G28, Q29, K57, T60, G61, Y67, S72, R79, N80, G81, R128, D129, H130, S131, Y132, Q133, E134, E135</DiscontinuousResidues>
                        <SourceMolecule>
                            <GenBankId>Q63345.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10116</SourceOrganismId>
                    </DiscontinuousRegionOnAccessionSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>116228</EpitopeId>
                <ReferenceRegion>G1, Q2, K30, T33, G34, Y40, S45, R52, N53, G54, R101, D102, H103, S104, Y105, Q106, E107, E108</ReferenceRegion>
                <EpitopeEvidenceCode>Author provided Identifier</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figures 2 and 3</LocationOfData>
                        <BCellId>1492301</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>Young adult</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>Q63345.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10116</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Cerebellar glycoproteins</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>6 doses of 50 μg 2 weeks apart</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The immunogen is a Thy-1 depleted preparation of rat cerebellar glycoproteins. The first and 2nd immunization were given in CFA and the 3rd to 5th in IFA. Three days prior to fusion, a final intravenous injection without adjuvant was administered. Details are from the cited reference, Linnington et al, J Neuroimmunol. 1984 6(6):387 [PMID: 6207204].</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>436</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3.0</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>The Fab antibody fragment contains the variable Fv domain of the mouse monoclonal antibody 8-18C5 and human IgG constant domain.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>chimeric humanized demyelinating mAb 8-18C5</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG1</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>8-18C5 chimeric Fab</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1PKQ_A</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1PKQ_B</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>MOG&lt;sup&gt;Igd&lt;/sup&gt;</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GQFRVIGPGHPIRALVGDEAELPCRISPGKNATGMEVGWYRSPFSRVVHLYRNGKDQDAEQAPEYRGRTELLKESIGEGKVALRIQNVRFSDEGGYTCFFRDHSYQEEAAVELKVEDPFYWINPGV</LinearSequence>
                                        <StartingPosition>28</StartingPosition>
                                        <EndingPosition>153</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>Q63345.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10116</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1PKQ</ComplexPdbId>
                            <AntibodyChain1PdbChain>B</AntibodyChain1PdbChain>
                            <AntibodyChain2PdbChain>A</AntibodyChain2PdbChain>
                            <AntigenChainPdbChain>E</AntigenChainPdbChain>
                            <ViewerFlag>Y</ViewerFlag>
                            <Comments>Compared with the structure of uncomplexed MOG(Igd) [PDB:1PKO], the FG loop of MOG(Igd) is slightly displaced after antibody binding, and several MOG(Igd) side chains are repositioned to enable optimal binding to antibody residues.</Comments>
                            <CuratedContacts>
                                <EpitopeResidues>E: G1C, Q2, T33, G34, Y40, S45, R52, N53, G54, R101, D102, H103, S104, Y105, Q106, E107, E108</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>A: N30A:L1, N30D:L1, Y32:L1, H92:L3, Y94:L3; B: W33:H1, R54:H2, R56:H2, T97:H3, M98:H3</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>815.0</ContactAreaForAntigen>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResidues>E: G1C, Q2, K30, T33, G34, Y40, S45, N53, G54, R101, D102, H103, S104, Y105, Q106, E107, E108</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>A: G30C, S30B, N30A, N30D, Y32, H92, Y94; B: T28, S31, F32, W33, E50, L52, R54, R56, G95, N96, T97, M98, V99, N100</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>815.5</ContactAreaForAntigen>
                                <ContactAreaForAntibody>796.1</ContactAreaForAntibody>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

